About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026 07-09-2026 at 4:05 PM EDT Imviva Biotech Receives FDA IDE Authorization for clonoSEQ® Assay in TENACITY-01 Clinical Trial 06-30-2026 at 8:30 AM EDT Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering 06-17-2026 at 6:00 AM EDT VIEW ALL NEWS Upcoming Events & Presentations Adaptive Biotechnologies Second Quarter Financial Results Jul 29, 2026 at 4:30 PM EDT Add to Outlook Add to Google Calendar Listen to webcast Past Events & Presentations William Blair 46th Annual Growth Stock Conference Jun 3, 2026 at 3:20 PM CDT Listen to webcast Presentation 2.4 MB Adaptive Biotechnologies First Quarter Financial Results May 5, 2026 at 4:30 PM EDT Listen to webcast Adaptive Biotechnologies Q1 2026 Earnings Presentation 533.1 KB TD Cowen 46th Annual Healthcare Conference Mar 2, 2026 at 11:50 AM EST Listen to webcast VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Jul 9, 2026 4:45 PM EDTData Provided by Refinitiv. Minimum 15 minutes delayed.
